Bill Gates once revealed that the same person who challenged his intellect as a teenager also pushed him into experimenting ...
Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...
President Trump's order also calls for expanded research and access to CBD, a legal and increasingly popular hemp-derived ...
"This risk is exacerbated by the fact that there is currently no proven, widely accepted standard to determine marijuana ...
US president’s order would categorise cannabis as less dangerous and remove it from grouping with heroin and LSD ...
Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald ...
President Trump has signed an executive order that could reclassify marijuana as a less dangerous drug. This move could ease ...
CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...
A new study shows that a single dose of LSD may ease anxiety and depression for months. Dr. Josh Eloge, Associate Director at Rush’s Depression Treatment Research Center, joined "ChicagoNOW" to ...
A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...
WASHINGTON (AP) — LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned ...
A single LSD dose eased anxiety symptoms for up to three months 65% of patients improved; nearly 50% went into remission Larger trials are planned before possible federal approval FRIDAY, Sept. 5, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results